Med BioGene Broadens Commercialization Team to Oversee Launch Preparations for LungExpress DxTM Gene Expression Test

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 23, 2008) - Med BioGene Inc. (TSX VENTURE:MBI), a life science company focused on the development and commercialization of genomic-based diagnostic tests for cancer and cardiovascular disease, is pleased to announce the appointment of Vineet Bansal as Director, Product Launch and Marketing, and Debbie Corazzelli as Senior Advisor, Diagnostics Commercialization.